Drug Type Chemical drugs |
Synonyms IMGS 203, IMGS203 |
Target |
Mechanism STING agonists(Stimulator of interferon genes agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Immunogenesis, Inc.Startup |
Active Organization Immunogenesis, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | Immunogenesis, Inc.Startup | 05 Nov 2024 |